Denmark / 5 Pharma Country Managers Talk Market Access
Long established as a premier early launch country for innovative medicines within Europe, the Danish market access…
Top Stories
Global / 3 Pfizer Country Managers on COVID-19 Vaccine Rollout & Learnings
The global push to vaccinate populations against COVID-19 has played out differently in different geographies, with a yawning gap still existing between vaccination rates in developed and developing economies and…
Sweden / A Global Testbed for AMR Incentive Models
Anders Blanck, CEO of Lif, the trade association for the research-based Swedish pharmaceutical industry, writes…
Singapore / New Pharma Country Report Download 2021
With outstanding fundamentals, including top-class universities and hospitals, a government cognizant of the…
Europe / Top 5 Pharma R&D Spenders
The Top Five countries in Europe ranked by amount spent on pharma R&D. While some of the continent’s largest…
Saudi Arabia / KAIMRC's Dr Ahmed Alaskar on KSA's Road to Clinical Trial Hub Status
Dr Ahmed Alaskar is executive director of the King Abdullah International Medical Research Center (KAIMRC);…
Canada / Concrete Steps Toward National Pharmacare
Writing in the September edition of DIA’s Global Forum magazine, Dr Judith Glennie examines the specific…
Latest Reports
In Conversation
Sam Volchenboum – Associate Professor of Pediatrics, Dean of Master’s Education, Associate Chief, Research Informatics Officer Associate Director, Institute for Translational Medicine, University of Chicago
Dr Sam Volchenboum outlines the progress that has been made in the paediatric oncology field in recent years and his hopes for its future. Dr Volchenboum also explains the important role that data will play in the new era of targeted and personalised therapies and the impact of the work that his research group at the University of Chicago is…
Rodrigo Rodriguez – General Manager, Middle East…
Rodrigo Rodriguez, general manager for Takeda’s Middle East cluster, discusses the company’s ambitions in the collective Saudi pharma market, which…
Ayman Sharaiha – Co-Founder & COO, Altibbi
Altibbi’s Ayman Sharaiha outlines the evolution of the company to date to become the largest digital health platform in MENA,…
Focus on Saudi Arabia
Saudi Arabia: Significant Steps Towards Clinical Trial Hub…
Clinical trials provide a pathway to innovation for clinicians and patients in countries like Saudi Arabia and form a key element of the country’s Vision 2030 national plan. As Saudi…
PharmaBoardroom’s Top 10 Most Read Interviews of 2021 (So…
PharmaBoardroom has spread its wings far and wide in 2021 (albeit digitally!), from well covered markets such as Singapore and Switzerland to new frontiers like Saudi Arabia. Our interviewees have…
3 Pfizer Country Managers on COVID-19 Vaccine Rollout &…
The global push to vaccinate populations against COVID-19 has played out differently in different geographies, with a yawning gap still existing between vaccination rates in developed and developing economies and…
Three Key Trends to Watch in Saudi Arabia’s Pharma…
Looking to diversify its economy while simultaneously improving its healthcare system, Saudi Arabia has been rolling out incentives for international companies to invest in local manufacturing. Here are three trends…
Read more: Saudi Arabia >>
Focus on Europe
Sweden as a Global Testbed for AMR Incentive Models
Anders Blanck, CEO of Lif, the trade association for the research-based Swedish pharmaceutical industry, writes about the challenges the world faces from antimicrobial resistance (AMR). Sweden has for decades been…
Health Technology Assessment in the EU: Back and Forth in…
Writing in the August edition of DIA's Global Forum, Sanofi R&D's Thomas Kühler outlines the bumpy journey towards the full adoption of Health Technology Assessment (HTA) across Europe. More…
Europe Pharma Industry Top 5 Rankings 2021
Drawing from the 2021 edition of the EFPIA's comprehensive annual data review of the European pharma industry, we present the Top 5 countries across a variety of pharma metrics: from…
3 Pfizer Country Managers on COVID-19 Vaccine Rollout &…
The global push to vaccinate populations against COVID-19 has played out differently in different geographies, with a yawning gap still existing between vaccination rates in developed and developing economies and…
Read more: Europe >>
Focus on Vaccines
3 Pfizer Country Managers on COVID-19 Vaccine Rollout &…
The global push to vaccinate populations against COVID-19 has played out differently in different geographies, with a yawning gap still existing between vaccination rates in developed and developing economies and…
South Africa Pharma News: Vaccines Made in Africa to Stay in…
A roundup of the latest news from South African pharma, including Aspen’s impressive annual growth, Adcock Ingram’s full year profit drop, and Entos Pharma’s approval for Phase II clinical rials…
Spain Enters the COVID-19 Vaccine Race Through Animal Health…
The Spanish pharma industry has entered the race to develop COVID-19 vaccines through an unexpected contender: an animal health company. HIPRA, headquartered in Catalonia, has received approval to begin human…
Enough COVID Vaccines for World Population Says IFPMA: Calls…
Pharma industry leaders have called for rich nations to stop stockpiling excess COVID-19 vaccine doses and stated that there will be enough production by the end of the year to…
Read more: Vaccines >>
Focus on APAC
Regulatory Cooperation & Joint Assessments in ASEAN
Writing in the September edition of DIA’s Global Forum magazine, Rosilawati Ahmad of Malaysia's National Pharmaceutical Regulatory Agency; Tharnkamol Chanprapaph of the Thai FDA; and Samvel Azatyan, Valerio Reggi, and…
3 Pfizer Country Managers on COVID-19 Vaccine Rollout &…
The global push to vaccinate populations against COVID-19 has played out differently in different geographies, with a yawning gap still existing between vaccination rates in developed and developing economies and…
Varian’s Kenneth Tan on the Future of Cancer Care in…
Kenneth Tan has been President for Asia Pacific & Japan at cancer-focused medical device player Varian since February 2019. In a recent conversation with PharmaBoardroom, Tan shared how an early…
APAC: Self-Medication in the Age of COVID: The…
Writing in the May edition of DIA’s Global Forum magazine, Toshiyoshi Tominaga of the Asia-Pacific Self-Medication Industry (APSMI) looks at the landscape for OTC medicines in the Asia-Pacific region today. Tominaga highlights…
Read more: APAC >>
Focus on Turkey
Turkey: A Pharma Talent Hotbed
Drawing on over a dozen interviews with C-level pharmaceutical industry executives in Turkey, PharmaBoardroom has compiled a strategic overview of Turkey’s pharma talent potential, including what local talent can offer…
Turkey’s Moment of Reckoning on Diabetes?
As COVID-19 began spreading through the world, the race to understand the disease by scientists and doctors took off. After just a few months, it became apparent that people with…
How Pricing is Straining Turkish Pharma’s Sustainability
Almost two decades after initiating large-scale health system reforms, Turkey has consolidated the provision of universal healthcare coverage to over 95 percent of the population. The effort, part of the…
Pharma Faces: Demet Russ, Janssen Turkey
After an international career spanning 25 years, Demet Russ returned to her native Turkey to lead the Janssen affiliate during a tumultuous time and is aiming to give back to…
Read more: Turkey >>
Focus on China
China Strives for First-In-Class Drug Innovation with New…
In a comprehensive new piece, European Patent Attorney André Bourgouin and Adjunct Professor at CEIBS Eric Bouteiller examine the potential impact of China's revision to its patent law on the…
China Pharma News: Fosun Sales up 20%; MNC Price Manoeuvres…
The latest news from Chinese pharma, including Fosun Pharma’s 2021 interim results; how AstraZeneca, Bayer, Eli Lilly, Merck & Co., Novartis, Novo Nordisk, and Sanofi have achieved China growth in…
China News Roundup: Sinopharm Looks to mRNA Vaccines; Hong…
The latest news from Chinese pharma and biotech, including news that state-owned Sinopharm is now developing its own mRNA vaccine; an update on Hong Kong’s biotech investment ecosystem three year…
China Biopharma Dealmaking Review H1 2021
The latest reporting on China biopharma dealmaking from MSQ Ventures, including the Top 10 biotech in-licensing deals in H1 2021, the Top 5 out-licensing deals, and Top 10 IPOs. …
Read more: China >>
Focus on USA
Note to Biogen: Your Marketing is Showing
In his latest PharmaBoardroom piece, John Singer looks at Biogen’s marketing campaign for its new Alzheimer’s drug, extending and linking the controversy to the grander strategic themes reshaping the ‘drug market’…
US Health Policy: FDA Calls for Federal Investigation of…
The latest from US health care policy, including the Senate budget deal funding for a range of major health care priorities; Biden’s proposed Advanced Research Projects Agency that would reshape…
Inserting the Patient Voice: Ethical Challenges in the Use…
Patient advocate and regular PharmaBoardroom contributor Monica Weldon examines how healthcare’s data revolution has thus far largely ignored the patient voice and argues for a more inclusive approach to drive…
Top 2021 Insights from Global Regulators
Over the past 12 months, PharmaBoardroom has spoken to the heads of several key regulatory bodies across the world. While the approval processes for COVID-19 vaccines have evidently been top…